Boston Scientific Corp. (BSX) announced Health Canada approval and market launch of the PROMUS Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System in Canada.
According to the company, the new stent system incorporates the platinum chromium alloy and innovative stent design of the PROMUS Element Stent with an enhanced catheter delivery system engineered for improved performance in treating patients with coronary artery disease. The company noted that it plans to begin marketing the product immediately in Canada.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.